Saturday, December 06, 2025 | 03:52 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Moderna Covid-19 vaccine stability could give it edge over Pfizer's version

The vaccine is more stable than expected at temperatures that ordinary refrigerators can provide

premium

The vaccine can be distributed using existing cold-chain shipping and storage infrastructure

Reuters
Moderna Inc’s experimental COVID-19 vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage infrastructure.

That opens the door for its early use in hard to reach places that might not be appropriate for Pfizer Inc’s vaccine which needs ultra-cold storage.

Here are details of how it could be distributed.

HOW COLD IS COLD STORAGE?
 
Moderna’s vaccine is stable for up to six months at a temperature of minus 20 degrees Celsius (-4 F), about home freezer levels, when shipped and stored.

The company said it expects the vaccine